title: Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab.
authors: Institute of Integrative Biology, University of Liverpool, Rheumatology Department, Royal Liverpool and Broadgreen Hospital and Institute of Ageing and Chronic Disease, University Hospital Aintree, University of Liverpool, Liverpool, Merseyside, UK.
authors: Helen L
authors: HL
authors: Wright
authors: Institute of Integrative Biology, University of Liverpool, Rheumatology Department, Royal Liverpool and Broadgreen Hospital and Institute of Ageing and Chronic Disease, University Hospital Aintree, University of Liverpool, Liverpool, Merseyside, UK.
authors: Devesh
authors: D
authors: Mewar
authors: Institute of Integrative Biology, University of Liverpool, Rheumatology Department, Royal Liverpool and Broadgreen Hospital and Institute of Ageing and Chronic Disease, University Hospital Aintree, University of Liverpool, Liverpool, Merseyside, UK.
authors: Roger C
authors: RC
authors: Bucknall
authors: Institute of Integrative Biology, University of Liverpool, Rheumatology Department, Royal Liverpool and Broadgreen Hospital and Institute of Ageing and Chronic Disease, University Hospital Aintree, University of Liverpool, Liverpool, Merseyside, UK.
authors: Steven W
authors: SW
authors: Edwards
authors: Institute of Integrative Biology, University of Liverpool, Rheumatology Department, Royal Liverpool and Broadgreen Hospital and Institute of Ageing and Chronic Disease, University Hospital Aintree, University of Liverpool, Liverpool, Merseyside, UK. rjmoots@liv.ac.uk.
authors: Robert J
authors: RJ
authors: Moots
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000276:immunology*; D013582:Synovial Fluid / Q000276:immunology*; D017211:Treatment Failure; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D000093242:Interleukin-6 Inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D000093242:Interleukin-6 Inhibitors; C508600:IL6 protein, human; C502936:tocilizumab